NM_012079.6:c.743C>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_012079.6(DGAT1):​c.743C>A​(p.Thr248Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0862 in 1,534,330 control chromosomes in the GnomAD database, including 6,325 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.062 ( 383 hom., cov: 33)
Exomes 𝑓: 0.089 ( 5942 hom. )

Consequence

DGAT1
NM_012079.6 missense

Scores

3
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.26

Publications

16 publications found
Variant links:
Genes affected
DGAT1 (HGNC:2843): (diacylglycerol O-acyltransferase 1) This gene encodes an multipass transmembrane protein that functions as a key metabolic enzyme. The encoded protein catalyzes the conversion of diacylglycerol and fatty acyl CoA to triacylglycerol. This enzyme can also transfer acyl CoA to retinol. Activity of this protein may be associated with obesity and other metabolic diseases. [provided by RefSeq, Jul 2013]
DGAT1 Gene-Disease associations (from GenCC):
  • congenital diarrhea 7 with exudative enteropathy
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0024031997).
BP6
Variant 8-144318103-G-T is Benign according to our data. Variant chr8-144318103-G-T is described in ClinVar as Benign. ClinVar VariationId is 402587.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0929 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012079.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DGAT1
NM_012079.6
MANE Select
c.743C>Ap.Thr248Asn
missense
Exon 8 of 17NP_036211.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DGAT1
ENST00000528718.6
TSL:1 MANE Select
c.743C>Ap.Thr248Asn
missense
Exon 8 of 17ENSP00000482264.1
DGAT1
ENST00000524844.1
TSL:3
n.128C>A
non_coding_transcript_exon
Exon 2 of 7
DGAT1
ENST00000524965.5
TSL:5
n.301C>A
non_coding_transcript_exon
Exon 4 of 12

Frequencies

GnomAD3 genomes
AF:
0.0618
AC:
9400
AN:
152220
Hom.:
384
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0183
Gnomad AMI
AF:
0.122
Gnomad AMR
AF:
0.0653
Gnomad ASJ
AF:
0.0565
Gnomad EAS
AF:
0.000962
Gnomad SAS
AF:
0.0387
Gnomad FIN
AF:
0.0456
Gnomad MID
AF:
0.0759
Gnomad NFE
AF:
0.0949
Gnomad OTH
AF:
0.0845
GnomAD2 exomes
AF:
0.0645
AC:
12270
AN:
190260
AF XY:
0.0670
show subpopulations
Gnomad AFR exome
AF:
0.0138
Gnomad AMR exome
AF:
0.0483
Gnomad ASJ exome
AF:
0.0583
Gnomad EAS exome
AF:
0.000180
Gnomad FIN exome
AF:
0.0463
Gnomad NFE exome
AF:
0.0968
Gnomad OTH exome
AF:
0.0772
GnomAD4 exome
AF:
0.0889
AC:
122883
AN:
1381992
Hom.:
5942
Cov.:
35
AF XY:
0.0879
AC XY:
59631
AN XY:
678752
show subpopulations
African (AFR)
AF:
0.0132
AC:
409
AN:
31022
American (AMR)
AF:
0.0500
AC:
1652
AN:
33046
Ashkenazi Jewish (ASJ)
AF:
0.0617
AC:
1274
AN:
20664
East Asian (EAS)
AF:
0.000154
AC:
6
AN:
39036
South Asian (SAS)
AF:
0.0430
AC:
3153
AN:
73340
European-Finnish (FIN)
AF:
0.0473
AC:
2349
AN:
49610
Middle Eastern (MID)
AF:
0.0686
AC:
370
AN:
5394
European-Non Finnish (NFE)
AF:
0.102
AC:
109081
AN:
1073020
Other (OTH)
AF:
0.0807
AC:
4589
AN:
56860
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
6145
12290
18434
24579
30724
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4010
8020
12030
16040
20050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0617
AC:
9397
AN:
152338
Hom.:
383
Cov.:
33
AF XY:
0.0589
AC XY:
4390
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.0183
AC:
760
AN:
41574
American (AMR)
AF:
0.0652
AC:
998
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0565
AC:
196
AN:
3472
East Asian (EAS)
AF:
0.000964
AC:
5
AN:
5188
South Asian (SAS)
AF:
0.0379
AC:
183
AN:
4828
European-Finnish (FIN)
AF:
0.0456
AC:
484
AN:
10622
Middle Eastern (MID)
AF:
0.0782
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
0.0949
AC:
6454
AN:
68026
Other (OTH)
AF:
0.0865
AC:
183
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
477
954
1430
1907
2384
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
104
208
312
416
520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0776
Hom.:
801
Bravo
AF:
0.0625
TwinsUK
AF:
0.0933
AC:
346
ALSPAC
AF:
0.108
AC:
416
ESP6500AA
AF:
0.0184
AC:
81
ESP6500EA
AF:
0.100
AC:
859
ExAC
AF:
0.0641
AC:
7731
Asia WGS
AF:
0.0410
AC:
144
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jan 24, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
20
DANN
Uncertain
0.98
DEOGEN2
Benign
0.30
T
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.058
FATHMM_MKL
Uncertain
0.96
D
MetaRNN
Benign
0.0024
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
2.0
M
PhyloP100
1.3
PrimateAI
Uncertain
0.63
T
Sift4G
Benign
0.14
T
Polyphen
0.089
B
Vest4
0.11
ClinPred
0.0053
T
GERP RS
3.8
Varity_R
0.20
gMVP
0.74
Mutation Taster
=63/37
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55962377; hg19: chr8-145541766; COSMIC: COSV107403790; COSMIC: COSV107403790; API